To further confirm the role of Mcl-1 in ONC213 + venetoclax induced cell death, THP-1 cells and two primary AML patient samples were treated with ONC213 in combination with the Mcl-1 inhibitor AZD5991. Here, MCL1 is linked to acute myeloid leukemia.